Mindray Medical (MR) Reports Q3 Adj-EPS of $0.33, Beats by 6c
More News related to MR
- Mindray Introduces Significant New Upgrade for M5 Ultrasound Platform
- Goldman Sachs Upgraded Mindray Medical (MR) to Conviction Buy
- Mindray to Hold Annual General Meeting in Hong Kong on December 15, 2009
- Mindray Medical to Exhibit at RSNA 2009 in Chicago, from November 29th to December 4th, 2009
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
More News related to Earnings
- Highlights From Staples' (SPLS) Q3 Conference Call: Corporate Express Integration on Track; Positive Consumer Traffic
- Highlights From GES's Q3 Conference Call: Each Business Segment Exceeded Expectations in Gross Revenues & Earnings
- Staples (SPLS) Slightly Beats Q3 Estimates, Sees Sales Rising In the Current Quarter
- Isle of Capri Casinos (ISLE) Reports Mixed Q2 Results
- Universal Technical Institute (UTI) Posts Q4 EPS of $0.32, Tops Street Views
Mindray Medical International LTD (NYSE: MR) reports Q3 EPS of $0.33, ex-items, 6 cents better than the analyst estimate of $0.27.
Related Categories
EarningsStocks Mentioned
+0.97Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
